Quantbot Technologies’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Sell
4,550
-3,237
-42% -$94.9K 0.01% 1335
2026
Q1
$192K Sell
7,787
-1,570
-17% -$27.5K 0.01% 1184
2025
Q4
$158K Sell
9,357
-2,175
-19% -$38.3K 0.01% 1298
2025
Q3
$251K Sell
11,532
-13,701
-54% -$227K 0.01% 1221
2025
Q2
$360K Buy
25,233
+17,439
+224% +$276K 0.01% 1087
2025
Q1
$101K Buy
+7,794
New +$118K ﹤0.01% 1240

Other funds holding ETON

Quantbot Technologies's ETON Position: Q2 2026 in Review

Quantbot Technologies reduced its Eton Pharmaceutcials (ETON) stake by 42% in Q2 2026, selling an estimated $94.9K and leaving 4,550 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #1335.

Quantbot Technologies first reported a position in ETON in Q1 2025 and has held it in 6 quarters since. The position peaked at $360K in Q2 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Quantbot Technologies held 4,550 shares of Eton Pharmaceutcials worth $165K as of Q2 2026.
  • Quantbot Technologies sold 3,237 Eton Pharmaceutcials shares in Q2 2026, an estimated $94.9K.
  • Eton Pharmaceutcials made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1335 holding.
  • Quantbot Technologies first reported a position in Eton Pharmaceutcials in Q1 2025 and has held it in 6 quarters since.
  • Quantbot Technologies's Eton Pharmaceutcials position peaked at $360K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.